CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination

Oncotarget. 2015 Sep 22;6(28):26308-21. doi: 10.18632/oncotarget.4763.

Abstract

Here we demonstrate that a ubiquitin E3-ligase, FBXO21, targets the multidrug resistance transporter, ABCB1, also known as P-glycoprotein (P-gp), for proteasomal degradation. We also show that the Ser291-phosphorylated form of the multifunctional protein and stem cell marker, CD44, inhibits FBXO21-directed degradation of P-gp. Thus, CD44 increases P-gp mediated drug resistance and represents a potential therapeutic target in P-gp-positive cells.

Keywords: drug resistance; ubquitination.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B / genetics
  • ATP Binding Cassette Transporter, Subfamily B / metabolism
  • Animals
  • BALB 3T3 Cells
  • Drug Resistance, Multiple* / genetics
  • Drug Resistance, Neoplasm* / genetics
  • F-Box Proteins / genetics
  • F-Box Proteins / metabolism*
  • Female
  • Humans
  • Hyaluronan Receptors / genetics
  • Hyaluronan Receptors / metabolism*
  • MCF-7 Cells
  • Mice
  • Phosphorylation
  • Proteasome Endopeptidase Complex / metabolism
  • Protein Binding
  • Protein Stability
  • Proteolysis
  • RNA Interference
  • Serine
  • Time Factors
  • Transfection
  • Two-Hybrid System Techniques
  • Ubiquitination*

Substances

  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • CD44 protein, human
  • F-Box Proteins
  • FBXO21 protein, human
  • Hyaluronan Receptors
  • Serine
  • Proteasome Endopeptidase Complex